New drugs have increased survival rates for men with metastatic prostate cancer
Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.
Uppsala Lan Marcus Westerberg Lily Ramsey National Prostate Cancer Register Department Of Surgical Sciences At Uppsala University Uppsala University
Source: news-medical.net